Life Sciences & Healthcare
Rapid transformation in the Life Sciences & Healthcare industry requires organisations to strike a balance between market potential, policy compliance and patient demands with continued innovation.
We are all affected by this sector and it falls under heavy social and political scrutiny. Regulation of competition in the sector has also made it increasingly dynamic and challenging. As the demand for life sciences and healthcare services is ever-growing, so too are the strains and scrutiny placed on its decision makers.
With the largest Life Sciences & Healthcare Team in de Dutch market, we can relate to our clients and deliver top tier services to our clients during all the stages of business lifecycle.
Recent changes in the Dutch healthcare system have allowed investors and care providers to operate from the Netherlands when deploying innovative care concepts. The relocation of the EMA to Amsterdam attracts also new pharmaceutical companies and generates a lot of activity.
Remodelling of the healthcare system has resulted in hospital mergers, partnerships, and reorganisation of healthcare. Besides that, E-Health plays an increased role in prevention and screening. This growth in innovation is evident across other Loyens & Loeff markets in Belgium, Switzerland and Luxembourg.
Product development in the pharma industry
Successfully developing and marketing products in the pharmaceutical and life sciences sectors requires first-rate legal and tax support. This support must include an expert understanding of clinical research, intellectual property, tax planning, regulatory compliance, and pricing issues.
The implications of the COVID-19 pandemic reach across borders, industries, and legal disciplines. That is why Loyens & Loeff has set up dedicated expert teams - to offer you an integrated answer to all your legal and tax questions related to the coronavirus outbreak.
Op 12 maart 2020 werd door het kabinet aangekondigd dat vanwege COVID-19 iedereen die daartoe in staat was de komende twee weken thuis moest werken.
Digital transformation is all about using the latest technology to improve your business model. Digital technology creates new business opportunities which in turn creates a whole new range of tax and legal challenges such as contracting, data protection, privacy questions, intellectual property, consumer protection and competition issues.
Over the past few weeks, we have discussed the main changes to Belgian consumer law resulting from the implementation of the so-called Digital Sales Directive and Omnibus Directive.